Omalizumab-induced paradoxical urticaria responsive to dupilumab
Ann Dermatol Venereol
.
2023 Dec;150(4):302-303.
doi: 10.1016/j.annder.2023.06.007.
Epub 2023 Sep 14.
Authors
A-C Fougerousse
1
,
A Badaoui
2
Affiliations
1
Dermatology Department, Military Teaching Hospital Begin, Saint Mandé, France; GEM Reso, Paris, France. Electronic address:
[email protected]
.
2
Dermatology Department, Military Teaching Hospital Begin, Saint Mandé, France; GEM Reso, Paris, France.
PMID:
37689535
DOI:
10.1016/j.annder.2023.06.007
No abstract available
Publication types
Letter